Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Popat

Cancer

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancer|February 16, 2019
Hyperprogression with immunotherapy: Is it real?Sanjay Popat
Cancer|October 28, 2008
Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapyAlex D Drilon, Sanjay Popat, Gauri Bhuchar, et al.
Cancer|April 16, 2013
Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patientsAndrew J Weickhardt, Robert C Doebele, W Thomas Purcell, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancer|February 16, 2019
Hyperprogression with immunotherapy: Is it real?Sanjay Popat
Cancer|October 28, 2008
Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapyAlex D Drilon, Sanjay Popat, Gauri Bhuchar, et al.
Cancer|April 16, 2013
Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patientsAndrew J Weickhardt, Robert C Doebele, W Thomas Purcell, et al.
Pageof 1